Title: MMI/Pfizer Course: Molecules to Medicines - How Biopharma Delivers - DAY 1
Read a report of the 2012 Molecules to Medicines course here
This MMI/Pfizer Course will be of interest to research students, academic staff and clinicians, whether contemplating a career in industry or doing translational research in academia. It will also be of interest to those already working in a commercial setting with an interest in the biopharmaceutical industry.
The lectures provide an overview of biopharmaceutical discovery, development and manufacturing, delivered by key staff from Pfizer.
Senior Staff from Pfizer (please see at the bottom of this page)
Lecture course Fees (does not include Workshop)
The registration charges do not include accommodation or travel. Please contact firstname.lastname@example.org for further information
Please note that in addition to the lecture course, there is a MMI/Pfizer Molecules to Medicines Workshop usually taking place on the day following the lecture course.
In the first instance this workshop is open to postgraduate students with research experience (e.g. at least one year into their PhD studies). There are a limited number of places available on the workshop. If places are available we will open attendance to postdoctoral staff also.
If you are interested in attending this workshop please send an email indicating your interest to education@MolecularMedicineIreland.ie after you have applied online for the lecture course (Attendance to the lecture course is compulsory in order to attend the workshop).
Please see here for further details on the workshop
A follow-up visit to the Pfizer Biotech campus at Grange Castle is also organised for a limited group of course attendees. Please also indicate whether you wish to attend the Pfizer Grange Castle Facility Tour when applying for the workshop.
Comments from participants on a previous run of the Lecture Course:
"This was a thoroughly enjoyable course, well recommended and superbly organized".
"I have already recommended to many people who can be interested".
"Extremely informative and enjoyable two days. Well impressed".
|1005||Introduction to the business of discovering biopharmaceuticals|
|1115||Current biopharmaceutical product candidates and a look into next generation technologies
Dr Patrick Gammel (Pfizer)
|1205||Current issues within the biopharmaceutical and how these are influencing development within the industry|
|1255||Lunch break (lunch will be provided)|
|1340||Cell line & Process development|
Dr Brian Hasset (Pfizer)
|1430||Introduction to the science and technology of biopharmaceutical manufacturing|
|1540||Focus on the application of molecular technologies in manufacturing environments|
|1630||Discussion & round up|
Click here for abstracts & biographies
|Back to top|
Dr Jonny Finlay (Global Biologic Therapeutics, Grange Castle, Ireland)
Dr Patrick Gammell (Principal Process Development Scientist, Pfizer Grange Castle, Ireland)
Dr Brian Hassett (Principal Scientist, Development Analytical Sciences, Pfizer)
The Molecules to Medicines Course and Workshop were originally initiated in 2006 as a collaboration with Wyeth Biopharma. They were first developped and delivered by Dr Davinder Gill (then Assistant Vice President, Biologic Therapeutics, Wyeth Pharmaceuticals, Cambridge, MA, USA), Dr Brendan Hughes (then Director of Development, Wyeth Medica Ireland, Grange Castle) & Dr Mark Leonard (then Director, Gene Expression Technologies, Wyeth BioPharma Campus, Andover, MA, USA).